|
US8417311B2
(en)
|
2008-09-12 |
2013-04-09 |
Optiscan Biomedical Corporation |
Fluid component analysis system and method for glucose monitoring and control
|
|
US7959598B2
(en)
|
2008-08-20 |
2011-06-14 |
Asante Solutions, Inc. |
Infusion pump systems and methods
|
|
US9757510B2
(en)
|
2012-06-29 |
2017-09-12 |
Animas Corporation |
Method and system to handle manual boluses or meal events for closed-loop controllers
|
|
US9486578B2
(en)
*
|
2012-12-07 |
2016-11-08 |
Animas Corporation |
Method and system for tuning a closed-loop controller for an artificial pancreas
|
|
US9907909B2
(en)
|
2012-12-20 |
2018-03-06 |
Animas Corporation |
Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
|
|
EP2943150B1
(en)
*
|
2013-01-14 |
2018-12-05 |
The Regents of The University of California |
Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
|
|
US9517306B2
(en)
|
2013-03-15 |
2016-12-13 |
Animas Corporation |
Method and system for closed-loop control of an artificial pancreas
|
|
WO2014149536A2
(en)
|
2013-03-15 |
2014-09-25 |
Animas Corporation |
Insulin time-action model
|
|
US9795737B2
(en)
|
2013-03-15 |
2017-10-24 |
Animas Corporation |
Method and system for closed-loop control of an artificial pancreas
|
|
US9561324B2
(en)
|
2013-07-19 |
2017-02-07 |
Bigfoot Biomedical, Inc. |
Infusion pump system and method
|
|
US9474855B2
(en)
|
2013-10-04 |
2016-10-25 |
Animas Corporation |
Method and system for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas
|
|
US9861747B2
(en)
|
2013-12-05 |
2018-01-09 |
Lifescan, Inc. |
Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing
|
|
GB2523989B
(en)
|
2014-01-30 |
2020-07-29 |
Insulet Netherlands B V |
Therapeutic product delivery system and method of pairing
|
|
CN106714874B
(zh)
|
2014-08-06 |
2019-10-08 |
加利福尼亚大学董事会 |
用于控制应用的滚动时域状态初始化器
|
|
AU2016219961B2
(en)
|
2015-02-18 |
2020-07-02 |
Insulet Corporation |
Fluid delivery and infusion devices, and methods of use thereof
|
|
HK1257246A1
(zh)
|
2016-01-13 |
2019-10-18 |
Bigfoot Biomedical, Inc. |
糖尿病管理系统的用户界面
|
|
US10307538B2
(en)
*
|
2016-01-14 |
2019-06-04 |
Bigfoot Biomedical, Inc. |
Adjusting insulin delivery rates
|
|
HK1256995A1
(zh)
|
2016-01-14 |
2019-10-11 |
Bigfoot Biomedical, Inc. |
药物输送设备、系统和方法中的阻塞解决方案
|
|
FR3047098B1
(fr)
*
|
2016-01-21 |
2018-05-25 |
Voluntis |
Gestion de l'equilibre glycemique d'un patient diabetique
|
|
EP3411109A4
(en)
*
|
2016-02-05 |
2019-07-10 |
Animas Corporation |
VISUALIZATION AND ANALYSIS TOOL FOR A DRUG DELIVERY SYSTEM
|
|
US12383166B2
(en)
|
2016-05-23 |
2025-08-12 |
Insulet Corporation |
Insulin delivery system and methods with risk-based set points
|
|
WO2018058041A1
(en)
|
2016-09-23 |
2018-03-29 |
Insulet Corporation |
Fluid delivery device with sensor
|
|
US11096624B2
(en)
|
2016-12-12 |
2021-08-24 |
Bigfoot Biomedical, Inc. |
Alarms and alerts for medication delivery devices and systems
|
|
US10500334B2
(en)
|
2017-01-13 |
2019-12-10 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US10881793B2
(en)
|
2017-01-13 |
2021-01-05 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US10583250B2
(en)
|
2017-01-13 |
2020-03-10 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
EP3568860B1
(en)
|
2017-01-13 |
2025-12-10 |
Insulet Corporation |
Insulin delivery methods, systems and devices
|
|
US10758675B2
(en)
|
2017-01-13 |
2020-09-01 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US11027063B2
(en)
|
2017-01-13 |
2021-06-08 |
Bigfoot Biomedical, Inc. |
Insulin delivery methods, systems and devices
|
|
US11497851B2
(en)
|
2017-03-31 |
2022-11-15 |
Lifescan Ip Holdings, Llc |
Maintaining maximum dosing limits for closed loop insulin management systems
|
|
US10729849B2
(en)
|
2017-04-07 |
2020-08-04 |
LifeSpan IP Holdings, LLC |
Insulin-on-board accounting in an artificial pancreas system
|
|
US11147920B2
(en)
|
2017-04-18 |
2021-10-19 |
Lifescan Ip Holdings, Llc |
Diabetes management system with automatic basal and manual bolus insulin control
|
|
CN116531603A
(zh)
|
2017-05-05 |
2023-08-04 |
伊莱利利公司 |
生理葡萄糖的闭环控制
|
|
EP3438858A1
(en)
|
2017-08-02 |
2019-02-06 |
Diabeloop |
Closed-loop blood glucose control systems and methods
|
|
JP7133625B2
(ja)
|
2017-12-21 |
2022-09-08 |
イーライ リリー アンド カンパニー |
生理的グルコースの閉ループ制御
|
|
JP6938363B2
(ja)
*
|
2017-12-27 |
2021-09-22 |
オムロンヘルスケア株式会社 |
情報処理装置、生体情報測定装置、方法及びプログラム
|
|
USD928199S1
(en)
|
2018-04-02 |
2021-08-17 |
Bigfoot Biomedical, Inc. |
Medication delivery device with icons
|
|
US11158413B2
(en)
*
|
2018-04-23 |
2021-10-26 |
Medtronic Minimed, Inc. |
Personalized closed loop medication delivery system that utilizes a digital twin of the patient
|
|
US11147919B2
(en)
|
2018-04-23 |
2021-10-19 |
Medtronic Minimed, Inc. |
Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system
|
|
US11565043B2
(en)
|
2018-05-04 |
2023-01-31 |
Insulet Corporation |
Safety constraints for a control algorithm based drug delivery system
|
|
CA3103479A1
(en)
|
2018-06-22 |
2019-12-26 |
Eli Lilly And Company |
Insulin and pramlintide delivery systems, methods, and devices
|
|
CN112789070A
(zh)
|
2018-09-28 |
2021-05-11 |
英赛罗公司 |
人造胰腺系统的活动模式
|
|
US11565039B2
(en)
|
2018-10-11 |
2023-01-31 |
Insulet Corporation |
Event detection for drug delivery system
|
|
USD920343S1
(en)
|
2019-01-09 |
2021-05-25 |
Bigfoot Biomedical, Inc. |
Display screen or portion thereof with graphical user interface associated with insulin delivery
|
|
US11986629B2
(en)
*
|
2019-06-11 |
2024-05-21 |
Medtronic Minimed, Inc. |
Personalized closed loop optimization systems and methods
|
|
US11801344B2
(en)
|
2019-09-13 |
2023-10-31 |
Insulet Corporation |
Blood glucose rate of change modulation of meal and correction insulin bolus quantity
|
|
US11935637B2
(en)
|
2019-09-27 |
2024-03-19 |
Insulet Corporation |
Onboarding and total daily insulin adaptivity
|
|
EP4069082B1
(en)
|
2019-12-06 |
2024-06-05 |
Insulet Corporation |
Techniques and devices providing adaptivity and personalization in diabetes treatment
|
|
US11833329B2
(en)
|
2019-12-20 |
2023-12-05 |
Insulet Corporation |
Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
|
|
AU2021206190A1
(en)
|
2020-01-06 |
2022-08-18 |
Insulet Corporation |
Prediction of meal and/or exercise events based on persistent residuals
|
|
EP4100958A1
(en)
|
2020-02-03 |
2022-12-14 |
Insulet Corporation |
Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
|
|
US11551802B2
(en)
|
2020-02-11 |
2023-01-10 |
Insulet Corporation |
Early meal detection and calorie intake detection
|
|
US11547800B2
(en)
|
2020-02-12 |
2023-01-10 |
Insulet Corporation |
User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
|
|
US11986630B2
(en)
|
2020-02-12 |
2024-05-21 |
Insulet Corporation |
Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
|
|
US11324889B2
(en)
|
2020-02-14 |
2022-05-10 |
Insulet Corporation |
Compensation for missing readings from a glucose monitor in an automated insulin delivery system
|
|
US12495994B2
(en)
|
2020-02-20 |
2025-12-16 |
Insulet Corporation |
Meal bolus subcategories in model based insulin therapy
|
|
US11607493B2
(en)
|
2020-04-06 |
2023-03-21 |
Insulet Corporation |
Initial total daily insulin setting for user onboarding
|
|
US12121700B2
(en)
|
2020-07-22 |
2024-10-22 |
Insulet Corporation |
Open-loop insulin delivery basal parameters based on insulin delivery records
|
|
US11684716B2
(en)
|
2020-07-31 |
2023-06-27 |
Insulet Corporation |
Techniques to reduce risk of occlusions in drug delivery systems
|
|
US12128215B2
(en)
|
2020-09-30 |
2024-10-29 |
Insulet Corporation |
Drug delivery device with integrated optical-based glucose monitor
|
|
WO2022072618A1
(en)
|
2020-09-30 |
2022-04-07 |
Insulet Corporation |
Secure wireless communications between a glucose monitor and other devices
|
|
US11160925B1
(en)
|
2021-01-29 |
2021-11-02 |
Insulet Corporation |
Automatic drug delivery system for delivery of a GLP-1 therapeutic
|
|
US12431229B2
(en)
|
2021-03-10 |
2025-09-30 |
Insulet Corporation |
Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
|
|
US11904140B2
(en)
|
2021-03-10 |
2024-02-20 |
Insulet Corporation |
Adaptable asymmetric medicament cost component in a control system for medicament delivery
|
|
US12496398B2
(en)
|
2021-05-28 |
2025-12-16 |
Insulet Corporation |
Threshold based automatic glucose control response
|
|
US12406760B2
(en)
|
2021-06-07 |
2025-09-02 |
Insulet Corporation |
Exercise safety prediction based on physiological conditions
|
|
US12514980B2
(en)
|
2021-06-30 |
2026-01-06 |
Insulet Corporation |
Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
|
|
US12521486B2
(en)
|
2021-07-16 |
2026-01-13 |
Insulet Corporation |
Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
|
|
US11738144B2
(en)
|
2021-09-27 |
2023-08-29 |
Insulet Corporation |
Techniques enabling adaptation of parameters in aid systems by user input
|
|
US11439754B1
(en)
|
2021-12-01 |
2022-09-13 |
Insulet Corporation |
Optimizing embedded formulations for drug delivery
|
|
WO2024147928A1
(en)
|
2023-01-06 |
2024-07-11 |
Insulet Corporation |
Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation
|
|
US20250166810A1
(en)
*
|
2023-11-22 |
2025-05-22 |
Cilag Gmbh International |
Data streams multi-system interaction
|